Severe left ventricular dysfunction in infants with ventricular preexcitation.
Cadrin-Tourigny
Julia
J
Electrophysiology Service, Montreal Heart Institute, University of Montreal, Montreal, Canada.
Fournier
Anne
A
Andelfinger
Gregor
G
Khairy
Paul
P
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000503:physiopathology*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D000077261:Carvedilol; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D011412:Propanolamines / Q000627:therapeutic use; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology*; D018879:Ventricular Premature Complexes / Q000188:drug therapy / Q000503:physiopathology*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy / Q000503:physiopathology*
D000317:Adrenergic alpha-Antagonists; D000889:Anti-Arrhythmia Agents; D002227:Carbazoles; D002316:Cardiotonic Agents; D004232:Diuretics; D011412:Propanolamines; D000077261:Carvedilol; D005665:Furosemide; D000638:Amiodarone